Alcohol injection around prostate may stall cancer spread
NCT ID NCT07100847
First seen Jun 24, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This early-stage study tests whether injecting alcohol around the prostate can block nerve signals that may help cancer grow and spread. Twenty-one men with high-risk prostate cancer who plan to have their prostate removed will receive one or two injections before surgery. Researchers will check if the treatment reduces nerve activity in the prostate and slows cancer progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dehydrated alcohol (ethanol) injected around the prostate
- What this could lead to
- If it works, this could point toward a way to slow or stop the spread of high-risk prostate cancer by blocking nerve signals.
- What could go wrong
- This is a very early Phase 1 trial with only 21 people, so it is not yet proven to work. The nerve block may not slow cancer growth and could affect sexual or urinary function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NERVES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?